Hørsholm, Denmark

Disa Tehler

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Disa Tehler. Retrieved from https://idiyas.com/inventor/disa-tehler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Disa Tehler: Innovator in Neurological Treatments

Introduction

Disa Tehler is a prominent inventor based in Horsholm, Denmark. He has made significant contributions to the field of biotechnology, particularly in the treatment of neurological disorders. His innovative work focuses on the development of oligonucleotides that can alter the splicing pattern of progranulin in cells.

Latest Patents

Disa Tehler holds a patent for an "Antisense oligonucleotide for targeting progranulin." This invention relates to oligonucleotides that have the potential to modify the splicing of progranulin, which is crucial for addressing various neurological conditions. His patent is a testament to his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Disa has been associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work there has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his research and innovations.

Collaborations

Disa Tehler has worked alongside notable colleagues such as Ravi Jagasia and Lars Jonson. These collaborations have fostered a dynamic environment for innovation and have contributed to the success of his projects.

Conclusion

Disa Tehler's contributions to the field of biotechnology, particularly through his patent on antisense oligonucleotides, highlight his role as a key innovator in the treatment of neurological disorders. His work continues to inspire advancements in medical research and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…